Search Results 201-210 of 17152 for egfr

  1. A Study to Evaluate Fertility, Sexual Function, and Endothelial Health in Premenopausal Women with Kidney Disease - Mayo Clinic

    Currently being evaluated for kidney transplant (eGFR < 20ml/min). Exclusion Criteria (Aim 1 & 2): Women who are currently pregnant. Prior history of ...

  2. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 (Cohort 1 and 3), or eGFR ≥ 30 to < 60 mL/min/1.73 m2 (Cohort 2 and 4), with eGFR calculated ...

  3. Belimumab With Rituximab for Primary Membranous Nephropathy (REBOOT) - Mayo Clinic

    eGFR ≥ 30 mL/min/1.73m2 while on maximally tolerated RAS blockade 5. Proteinuria: 1. ≥ 4 and \< 8 g/day that has persisted for at least the previous 3 ...

  4. Publications - B Selnur Erdal, Ph.D. - Mayo Clinic

    Correlation of epidermal growth factor receptor (EGFR) mutation profile with computed tomography (CT) imaging features in lung adenocarcinomas J Clin Oncol.

  5. A Study to Evaluate the Safety and Diagnostic Effectiveness of Mangoral in Patients With Focal Liver Lesions and Reduced Kidney Function - Mayo Clinic

    - Severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m^2) based on medical history and previous laboratory examinations ...

  6. Evaluating a Mobile Health Monitoring Platform for Capturing Patient-centered Outcomes Among Heart Failure Patients - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) < 20 mL/min/1.73 m^2 or receiving dialysis at screening. Routinely scheduled outpatient intravenous infusions ...

  7. MSC for Occlusive Disease of the Kidney - Clinical Trials

    Advanced CKD: Stage 5 (two kidney eGFR < 15 ml/min/1.73 m2) contralateral renal artery occlusion/stenosis above 75% or ESRD requiring dialysis; Clinically ...

  8. A Clinical Study To Investigate The Efficacy And Safety Of An Investigational Combination Therapy With BNT324 And BNT327 In Patients With Advanced Lung Cancer - Mayo Clinic

    NSCLC, non-squamous, AGA-positive, progressed on or recurred after at least one prior treatment with third generation TKI for EGFR-mutant disease, or ...

  9. A Study of the Potential for Polyethylene Glycol (Miralax) to Metabolize into Toxic Oxalate - Mayo Clinic

    Have an eGFR of below 60 mL/min/1.73m2 or a 24 hour urine oxalate level of > 0.46 mmol (the upper limit of normal per our laboratory); Women will be excluded ...

  10. Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery - Mayo Clinic

    Any prior treatment with erlotinib or other agent whose primary mechanism of action is known to inhibit EGFR; Participants with a known diagnosis of human ...